@article{32275ba75885433a85becd7dc0466c07,
title = "Continued search for therapies to favorably modify phosphate and FGF23 levels in CKD",
keywords = "Atrial fibrillation, CKD, Cardiovascular diseases, Fibroblast growth factor 23, Fibroblast growth factors, Heart failure, Hosphate binders, Humans, Hyperphosphatemia, Hypertrophy, left ventricular, Inflammation, Leukocytes, Myocytes, cardiac, Phosphates, Renal insufficiency, chronic, Risk factors",
author = "Rupal Mehta and Tamara Isakova",
note = "Funding Information: This work was supported by the National Institute of Health grant R01DK102438 (to T.I.) and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK110087 (to T.I.).",
year = "2017",
month = dec,
day = "7",
doi = "10.2215/CJN.11011017",
language = "English (US)",
volume = "12",
pages = "1911--1913",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "12",
}
